Valuing clinical strategies early in their development.
Welch
H G
HG
D003362:Cost-Benefit Analysis; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D013673:Technology Assessment, Biomedical
D016178:Granulocyte-Macrophage Colony-Stimulating Factor